Page last updated: 2024-12-04

aminoacetone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aminoacetone: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

aminoacetone : A propanone consisting of acetone having an amino group at the 1-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID215
CHEBI ID17906
MeSH IDM0049091

Synonyms (32)

Synonym
1-aminopropan-2-one
CHEBI:17906
2-propanone, amino- (6ci)
2-propanone, 1-amino- (8ci,9ci)
2-propanone, 1-amino-
alpha-aminoacetone
2-propanone, amino-
C01888
aminoacetone
1-amino-2-propanone
298-08-8
zb4es38s4r ,
unii-zb4es38s4r
AKOS010297672
.alpha.-aminoacetone
BCDGQXUMWHRQCB-UHFFFAOYSA-N
1-amino-propan-2-one
J-504205
f3v ,
DTXSID10183939
aminoacetone (hydrochloride)
1-amino-(8ci,9ci)-2-propanone
amino-(6ci)-2-propanone
amino-2-propanone
1-aminoacetone
mfcd00869738
BCP21992
Q4545767
FT-0724650
AMY25062
D87844
EN300-54739

Research Excerpts

Overview

Aminoacetone (AA) is a threonine metabolite accumulated in threoninemia, cri-du-chat, and diabetes. It contributes toward the formation of methylglyoxal (MG) in conditions of ketosis.

ExcerptReferenceRelevance
"Aminoacetone (AA) is a threonine and glycine metabolite overproduced and recently implicated as a contributing source of methylglyoxal (MG) in conditions of ketosis. "( Aminoacetone induces loss of ferritin ferroxidase and iron uptake activities.
Araki, D; Bechara, EJ; Dutra, F, 2003
)
3.2
"Aminoacetone (AA) is a threonine metabolite accumulated in threoninemia, cri-du-chat, and diabetes, where it contributes toward the formation of cytotoxic and genotoxic methylglyoxal (MG). "( Aminoacetone induces iron-mediated oxidative damage to isolated rat liver mitochondria.
Bechara, EJ; Dutra, F, 2004
)
3.21
"Aminoacetone (AA) is a threonine and glycine catabolite long known to accumulate in cri-du-chat and threoninemia syndromes and, more recently, implicated as a contributing source of methylglyoxal (MG) in diabetes mellitus. "( Aerobic oxidation of aminoacetone, a threonine catabolite: iron catalysis and coupled iron release from ferritin.
Bechara, EJ; Curi, D; Dutra, F; Knudsen, FS, 2001
)
2.07
"Aminoacetone would appear to be an endogenously occurring amine with a Km for metabolism by SSAO far lower than other aliphatic and aromatic biogenic amines examined previously as potential physiological substrates for the human vascular enzyme and possible implications of this are discussed."( The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery.
Chalmers, J; Lyles, GA, 1992
)
1.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
propanonesA ketone that is propane carrying at least one oxo substituent.
methyl ketoneA ketone of formula RC(=O)CH3 (R =/= H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
Glycine and Serine Metabolism2452
Dimethylglycine Dehydrogenase Deficiency2452
Dihydropyrimidine Dehydrogenase Deficiency (DHPD)2452
Sarcosinemia2452
Non-Ketotic Hyperglycinemia2452
Hyperglycinemia, Non-Ketotic2452
3-Phosphoglycerate Dehydrogenase Deficiency2452
L-Threonine Degradation to Methylglyoxal212
Glycine and Serine metabolism ( Glycine and Serine metabolism )3649
threonine degradation III (to methylglyoxal)012
superpathway of threonine metabolism034
aminopropanol biosynthesis08
Biochemical pathways: part I0466
threonine catabolism114

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (40.68)18.7374
1990's8 (13.56)18.2507
2000's15 (25.42)29.6817
2010's9 (15.25)24.3611
2020's3 (5.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.08 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index62.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other56 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]